Easy to incorporate new #RadOnc technology on presumption of ⬆️ outcomes. Agree with authors - clinical trial needed to understand impact of FL avoidance on toxicities & patient outcomes. ⁦TROG Cancer Research⁩ VITAL trial designed for this Q but needs $ sciencedirect.com/science/articl…

How does your MDM discuss older cancer patients?
🇨🇦 study 👉🏽 only 20% stated frailty. Comorbidity (51%) & age (33%) more common. No formal CGA. Exploring the Language Used to Describe Older Patients at MDMs ⁦Department of Supportive Care⁩ ⁦SIOG⁩ mdpi.com/2072-6694/16/8…

Value of #GeriOnc MDT on patient care in a community-based, academic cancer center for 80+y patients
👉🏽32.6% received SOC
👉🏽18.5% optimisation 👉🏽 69.8% able to receive SOC
👉🏽49% best supportive care ⁦University of Maryland Medical System⁩ ⁦SIOG⁩ sciencedirect.com/science/articl…

👏🏽👏🏽👏🏽 Vicky Chin on PhD pub. Dosimetric impact of delineation and motion uncertainties on the heart and substructures in lung cancer radiotherapy - Clinical Oncology clinicaloncologyonline.net/article/S0936-… James Otton UNSW South West Sydney Clinical Campuses Phil Chlap Gerard Walls

A pleasure to host this podcast interviewing ML Yap Clare B #Radiotherapy is indicated in ~77% of patients with #lungcancer yet only ~40% receive this in NSW, fewer elsewhere. How can we change this? Listen and find out. Targeting Cancer RANZCR Rad Oncology IASLC

…and here I was only thinking about systemic therapy +/- SBRT for oligometastatic disease. #radonc Abhishek Solanki Puneeth Iyengar Shankar Siva Dr. David Palma Docace911 redjournal.org/article/S0360-…

Nice to hear our article received enough downloads to be a #TopDownloadedArticle in JMIRO. Superbly led by Susan Harden We share a mutual interest in improving #quality in #RadOnc . onlinelibrary.wiley.com/doi/full/10.11…

Nice to see this important aspect of #RadOnc work quantified. Worried that peer review performed in <50% of cases & 56% #RadOnc not having time to do this. How can we improve this ⁦Katie Spencer⁩ How long does contouring really take? clinicaloncologyonline.net/article/S0936-…

So proud 👏🏽👏🏽👏🏽 Madame TROG president ⁦Puma Sundaresan⁩ ⁦TROG Cancer Research⁩ #TROG2024 ⁦RANZCR Rad Oncology⁩

Great overview of QOL ⁦💉💉💉A/Prof. Haryana Dhillon💉💉💉⁩ #TROG2024 . ⁦TROG Cancer Research⁩ Routine screening for psychosocial distress important for all people with #cancer

⁦Dr Deme Karikios⁩ presents on ⁦Common Sense Oncology⁩ at #TROG2024 . Clinical trials need endpoints that matter to patients ⁦TROG Cancer Research⁩

Variability in composition and functioning of #LCSM MDTs in 🇦🇺🇳🇿Low no of #lungcancer nurses, low representation of Nuc Med, low provision of smoking cessation. onlinelibrary.wiley.com/doi/10.1111/re… Jess Nash fraser brims LUCAP Australia We need to do better!

‘Decentralising editorial boards, addressing the language bias towards English and establishing independent regional-level citation databases can contribute to improving the quality and representation of Global South journals.’

📣 New Commentary

💯

Thanks Jessica Pearce for pushing us to do this analysis. Such a simple tool with such a powerful prognostic ability. #gerionc #geriheme OncoAlert Tata Memorial Hospital Anant Ramaswamy

At TOGA, we recognise the invaluable contributions of women in Thoracic Oncology. Today serves as a reminder that enhancing women's roles in science and technology is crucial, especially in advancing our mission for ground-breaking lung cancer research.